New app aims to get COVID-19 shots into arms faster and more efficiently

Healthcare tech company, Pharmapod, has developed a new cloud-based app that supports a speedier global COVID-19 vaccination process. 

Pharmapod’s Clinical Service app, which is now available in Canada, helps manage mass bookings, offers pre-eligibility screening, supports the set-up of vaccination centres and connects with patients digitally. The online booking system reduces the number of appointments that are missed and helps predict vaccine inventory levels. It allows administrators to modify eligibility criteria to coordinate the prioritization of high-risk groups first and then assign specific users different levels of access within the app based on their eligibility criteria.

Leonora O’Brien, Pharmapod’s Founder. “Our Clinical Service app was developed by pharmacists who have experience on the frontline of this pandemic and they recognize the current logistical challenges and inefficiencies. This system is designed with those factors in mind to help maximize rollout efficiency while minimizing distribution complexity. The app is designed for healthcare professionals to make each step clear, easy and fast in an effort to get as many shots in arms as quickly, safely and painlessly as possible.”

It’s easy for patients to book an appointment online. The system can send out important appointment reminder notifications and store patient records. On the app, patients can also fill out their eligibility criteria and alert the administering organization of any critical data, such as reports of vaccine side-effects.

The company’s software is used by over 60 percent of Canadian pharmacies and has now expanded into the United States. Pharmapod is a cloud-based, medication incident management, and business intelligence tool, specializing in pharmacy, specialty pharmacy, and long-term care facilities.

Check Also

CFI launches 2023 major science initiatives fund competition

The Canada Foundation for Innovation (CFI) has issued a call for proposals for the 2023 Major Science Initiatives fund competition.